about
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series.Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomasCarbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degenerationParaneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assaysAutoimmune post-herpes simplex encephalitis of adults and teenagersLymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literatureInvestigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapyNeuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusAbsence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis.Human neurexin-3α antibodies associate with encephalitis and alter synapse development.Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum DisorderParaneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies.The expanding field of IgG4-mediated neurological autoimmune disorders.Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Investigations in GABAA receptor antibody-associated encephalitis.Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.Understanding anti-IgLON5 disease.STEM-08INHIBITION OF THE NEURAL STEM CELL/OLIGODENDROCYTE PROGENITOR FACTOR GPR56 PROMOTES THE PRONEURAL TO MESENCHYMAL TRANSITION AND RADIORESISTANCE IN GLIOBLASTOMA.P11.06LYMPHOMATOSIS CEREBRI: A RARE FORM OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA.P17.70CAN ELDERLY PATIENTS WITH GLIOBLASTOMA BENEFIT FROM CONVENTIONAL CHEMO-RADIOTHERAPY TREATMENT?Autoimmune encephalitis with GABAA receptor antibodies in a 10-year-old girl.GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.DPPX antibody-associated encephalitis: Main syndrome and antibody effects.Seizure-susceptible brain regions in glioblastoma: identification of patients at risk.Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?-Authors' reply.Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies.Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.
P50
Q30584294-B0AAAA77-36EE-4996-AC9A-30268F6DC14FQ31170227-B4D1131E-DBBB-4EBF-AD30-BAA4574D4966Q33457740-E6978684-AD44-42A7-9F76-A73FAA2B31F4Q33591024-0A2C84B4-8975-40C4-A2CC-C1DF94825F49Q33714734-C731DEB9-6107-4718-9B21-93D5C2CBD479Q33831472-30EFC80D-07D6-4040-9D54-4458E4B61ABBQ34481818-E3F59198-A57D-4CA1-81A0-B16A295CCA92Q35041142-CB3492C7-BE4A-4062-A4F1-DF3ED48649A3Q36300045-3DB87A1C-4DAE-4FCF-AC96-8452BF144286Q36785116-44A1DB77-7F85-4A0D-BC93-05129F71EE7CQ36813361-43F30F0E-E932-40A6-AE73-3C1C6FC61C6BQ36813368-72AEDDB0-5576-41EA-89D8-D7E8D15198EAQ36826497-0E441C3E-4D89-4914-94A2-C9317C8AFFA8Q36827205-F9D8E26B-E1E2-48A8-B28F-93E2282C2443Q36865000-9E2A8A8C-DE93-460C-B58F-E9D44FC89AE9Q37008928-73334960-7448-4E8A-87A5-3FDF147D2B62Q37250508-A3C1EE9E-BB26-4C3F-88EA-E56E3C05BC39Q37626028-9D5A3597-1E23-42D0-82D3-C2EF8044585AQ38511298-CC361295-EF91-4EEE-B572-2A43C5D967DBQ38758942-F5EE2944-5692-4B59-A6FD-4436B09AA823Q39180685-E7EB1248-4109-4B3D-9BA0-3ED847F738C4Q40334397-41678723-3B5D-4194-88F6-18426467CA21Q41127137-43475AA2-6059-42B8-9F34-072C788B6B6AQ42349934-E7C9C26D-0184-41D8-8C9B-4C29730925B8Q45835645-D81A8D2D-76A9-4E51-B614-A7574979D69AQ46882641-91F00C4A-76C2-48B9-840F-561CAC2AB88BQ46885636-A97DA53E-AC6A-4CE1-BA1A-9130034DF8E3Q47289570-5900CB69-B6D5-48E5-A583-360D75EE9DBDQ47373348-096B2CE4-E438-41FA-A3D5-7B04D9A5502EQ47618323-1DE4822B-FA48-4D31-8632-ADC28F6BF8F3Q47786064-A1B92BC6-1513-4FAD-951B-843B15D56622Q47980187-7CA39689-CAB8-4B7A-9802-8D82D6510BC1Q48035578-94B91A29-8E74-46C5-850C-6EE8B59B5627Q48375267-4EF577DC-87BE-4C15-942D-645735E876BCQ48768047-A3C7F69A-5837-44C9-9F47-B1539C16799BQ50048448-9970D33A-4E97-4E44-AFFC-94F406375EB2Q50224993-FA0C6481-50DF-4151-8376-4B52962018D5Q51115638-F85E582A-D6A4-4EA8-BA9D-1181704DC2ACQ52149417-F7BA64C7-9BF7-4587-9B2C-63B74EE658DAQ52804045-9B8364D4-5AF7-4EE0-A693-4D9DA0A8FD58
P50
description
investigador
@es
researcher
@en
name
Francesc Graus
@en
type
label
Francesc Graus
@en
prefLabel
Francesc Graus
@en
P31
P496
0000-0002-8924-8322